The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumQuick Picks - Shares of ArQule (NASDAQ:ARQL) are being crushed in early trading on Tuesday following an announcement that the company and partner Daiichi Sankyo (OTC:DSNKY) will be … Continue Reading
Read nowLong Ideas - Major Drug and Diagnostics company, Roche Holdings (OTC:RHBBY) appears to be coming back to the table to take another run at acquiring Illumina (NASDAQ:ILMN), according … Continue Reading
Read nowLong Ideas - By now, the bear story on Questcor Pharmaceuticals (NASDAQ:QCOR) is well understood, with health insurer Aetna (NYSE:AET) indicating that it will make it next-to-impossible to … Continue Reading
Read nowLong Ideas - With Wall Street Analyst price targets on Ariad Pharmaceuticals (NASDAQ:ARIA) averaging $24.75 through this morning, new data for an early-stage pipeline candidate is causing price … Continue Reading
Read nowMost Popular - By David Moskowitz Peregrine Pharmaceuticals (NASDAQ:PPHM) opened down in early trading, as investors are still getting over the shock of the favorable clinical trial results … Continue Reading
Read nowInterviews - With Orphan Drug status and a largely-unmet medical need for its primary indication, ADVENTRX Pharmaceuticals (AMEX:ANX) expects its lead candidate, ANX-188, to be the company’s … Continue Reading
Read nowRecap - Shares of HEB furtively peaked on Monday following an announcement that Ampligen’s advisory committee meeting date had been set, but shares were unsuccessful in maintaining … Continue Reading
Read now
